Anti-TNFα Drugs and Interleukin Inhibitors: Epidemiological and Pharmacovigilance Investigation in COVID-19 Positive Patients

Anti-TNFα Drugs and Interleukin Inhibitors: Epidemiological and Pharmacovigilance Investigation in COVID-19 Positive Patients

Cytokine patterns and immune activation in patients with Coronavirus 2019 (COVID-19) seem to resemble the case of rheumatoid arthritis (RA), psoriasis and inflammatory bowel disease (IBD). Biological drugs, such as anti-tumor necrosis factor α (TNFα) and interleukin (IL) inhibitors, appear to be pro...

Full description

Bibliographic Details
Main Authors: Zaira Maraia, Tony Mazzoni, Marco Bruno Luigi Rocchi, Denise Feliciani, Maria Chiara Romani, Giovanna Acciarri, Stefania Rafaiani, Isidoro Mazzoni
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Journal of Personalized Medicine
Subjects:
anti-TNFα
IL-inhibitors
rheumatoid arthritis
psoriasis
inflammatory bowel disease
COVID-19
Online Access:https://www.mdpi.com/2075-4426/12/11/1770

Internet

https://www.mdpi.com/2075-4426/12/11/1770

Similar Items